Articles by Scott Gottlieb

First, Do No Harm

Eight years ago, working on the public offering of the Salt Lake City-based biotechnology company Myriad Genetics, I thought I found the next Microsoft. Myriad was the discoverer of BRCA1, the so-called breast cancer gene, which left women who harbored... Read More

Scott Gottlieb: Monthly Archives

TCS Daily Archives